Bio-Rad Laboratories and Beckman Coulter expands cooperation

Bio-Rad Laboratories, a global provider of life science research and clinical diagnostic products, announced that Bio-Rad is extending its agreement with Beckman Coulter and has named the company exclusive global distributor of Bio-Rad's Access HIV combo assay and the Access hepatitis C virus (HCV) assay in select geographies.

The 10-year exclusive distribution rights agreement is part of an extension of the manufacturing and supply agreement between the companies for immunodiagnostic testing for blood virus and infectious disease, which began nearly 20 years ago.

"This partnership with Bio-Rad enables Beckman Coulter Diagnostics to deliver on its commitment to customers by providing a broad immunoassay menu that allows them to optimize laboratory workflow," said John Blackwood, Senior Vice President, Chemistry and Immunoassay Business Unit, Beckman Coulter Diagnostics. "With the new HIV combo assay and HCV assay running on the Beckman Coulter UniCel DxI and Access systems, we enable physicians to better diagnose and treat patients with blood viruses and infectious diseases."

"We are pleased to extend our partnership with Beckman Coulter Diagnostics and believe the expertise of our respective organizations will add significant contributions to both HIV and hepatitis C testing laboratories and ultimately patient care," said John Hertia, Bio-Rad Executive Vice President, President, Clinical Diagnostics Group. "The strengthening of our partnership reflects each organization's commitment in providing high value testing for these diseases."


Source: Bio-Rad Laboratories

21.04.2015

Read all latest stories

Related articles

Photo

Sponsored • Infection management

New sepsis marker speeds up detection and therapy

Sepsis is the cause of one in five deaths worldwide, killing nearly 11 million people each year, many of them children. It is also a major cause of disability, affecting millions more. To combat the…

Photo

Interview • Urinalysis for Covid-19 diagnostics

Automation to relieve pandemic pressure from laboratories

To provide a solution for the challenges of the coronavirus pandemic, Beckman Coulter recently launched the DxU Iris, a urinalysis solution which aims to improve lab workflows.

Photo

Sponsored • Lab equipment

Minimising laboratory errors with automation

Staffing shortages, increased testing volumes and the need to improve turnaround times have led to labs seeking to streamline services. Automation is the key, thanks to the role it plays in…

Related products

Beckman Coulter – Access 2 Immunoassay System

Immunoassays

Beckman Coulter – Access 2 Immunoassay System

Beckman Coulter Diagnostics
Beckman Coulter – Access Procalcitonin (PCT)

Immunoassays

Beckman Coulter – Access Procalcitonin (PCT)

Beckman Coulter Diagnostics
Beckman Coulter – AU5800 Series

Clinical Chemistry

Beckman Coulter – AU5800 Series

Beckman Coulter Diagnostics
Beckman Coulter  – AutoMate 2500 Family Sample Processing Systems

Sample Processing

Beckman Coulter – AutoMate 2500 Family Sample Processing Systems

Beckman Coulter Diagnostics
Beckman Coulter – Diazyme Human Kappa & Lambda FLC assays

Clinical Chemistry

Beckman Coulter – Diazyme Human Kappa & Lambda FLC assays

Beckman Coulter Diagnostics
Subscribe to Newsletter